Goldman Sachs Group »

Mersana Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Mersana Therapeutics (MRSN) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Mersana Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mersana Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mersana Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.5M 1.2M 2.01
2024-03-31 $3.0M 673k 4.48
2023-12-31 $338k 146k 2.32
2023-09-30 $428k 337k 1.27
2023-06-30 $4.6M 1.4M 3.29
2023-03-31 $12M 2.9M 4.11
2022-12-31 $12M 2.0M 5.86
2022-06-30 $8.6M 1.9M 4.62
2022-03-31 $6.6M 1.7M 3.99
2021-12-31 $7.5M 1.2M 6.22
2021-09-30 $11M 1.1M 9.43
2021-03-31 $19M 1.2M 16.18
2020-12-31 $28M 1.0M 26.61
2020-09-30 $11M 596k 18.62
2020-06-30 $11M 452k 23.40
2019-12-31 $368k 64k 5.73
2019-09-30 $116k 73k 1.58
2019-06-30 $164k 41k 4.04
2019-03-31 $128k 24k 5.28
2018-12-31 $121k 30k 4.09
2018-09-30 $336k 34k 10.00
2018-06-30 $247k 14k 17.89
2018-03-31 $381k 24k 15.75
2017-12-31 $247k 15k 16.44
2017-06-30 $699k 50k 13.98